Table of Contents
Nearly two months back, a U.S. individual bankruptcy court choose accepted a controversial Purdue Pharma approach that would funnel billions of pounds to pay out for the damage prompted by the OxyContin opioid painkiller.
At the main, the deal calls for some associates of the Sackler family — which controlled Purdue — to contribute a lot more than $4.3 billion above almost a ten years to compensate people today, point out and community governments, and tribal communities for the price of the opioid disaster. The offer was in reaction to some 3,000 lawsuits that prompted the company to find personal bankruptcy in 2019. But even while the plan was accepted, the money has not begun flowing and it stays unclear when that will transpire.